Overview

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and effectiveness of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or candidemia.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Antifungal Agents
Caspofungin
Echinocandins
Micafungin
Miconazole